REMLIFANSERIN
UNII H4L2AF2XB7

Substance Identification & Data

This profile provides standardized clinical and technical data for Remlifanserin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) H4L2AF2XB7.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2289704-13-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

H4L2AF2XB7

CAS Registry Number

2289704-13-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

REMLIFANSERIN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C24H29F2N3O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

UYRCLXJMWZFKDG-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C213400

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

137520242

Unique identification number in the NCBI database of chemical substances.

INN ID

13254

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1cc(CN(C2CCN(C)CC2)C(NCc3ccc(cc3)OC4CC4)=O)c(cc1F)F

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Remlifanserin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.